Philadelphia is ending its indoor mask mandate, health officials said on April 21, reversing the city’s decision just days after imposing the order.
The BA.2 Omicron subvariant of the coronavirus is responsible for 86% of U.S. COVID-19 cases and more than 90% of infections in the Northeast, according to data on April 12 from the U.S. Centers for Disease Control and Prevention (CDC).
Philadelphia will again require masks in indoor public settings such as restaurants, schools and businesses starting next week, the city said on April 11, responding to what appears to be a fresh wave of coronavirus transmissions.
GlaxoSmithKline announced the British pharma leader’s intention to leave the sprawling campus in Research Triangle Park, N.C. for the more compact confines of a downtown Durham, N.C. space.
Philadelphia, also known as Cellicon Valley, has become a lynchpin hub for cell and gene therapy in the United States. As one of the fastest-growing hubs in the country, there is a growing demand for new lab space to accommodate merging and expanding companies.
Pennsylvania Governor Tom Wolf on Aug. 31 issued a mask mandate for all K-12 school and child care facilities to protect against the spread of Covid-19, three weeks after the Democrat said he would leave the decision to individual districts.
Cigna Corp. said on Aug. 26 the company would now sell health insurance plans on online marketplaces created by the Affordable Care Act (ACA), popularly known as Obamacare, in three new U.S. states and 93 new counties.
At least seven people in five U.S. states were infected with the novel coronavirus weeks before those states reported their first cases, a new government study showed.
PRECISIONscientia announced the Pennsylvania-based full-service medical communications agency is an honoree in the Philadelphia Business Journal’s 2021 Best Places to Work Awards in the large company category. Voted by the people who know them best—its employees—the award celebrates the top companies in the Greater Philadelphia area. This marks the second consecutive year that PRECISIONscientia made the annual list.
CEO Usama Malik is leading an exciting period of growth for Fore Biotherapeutics as the company evolves as a leader in precision oncology with its unique business model and ability to deliver the right therapies to currently underserved patients.